• Profile
Close

Increased one-year continuation of DMPA among women randomized to self-administration: Results from a randomized controlled trial at Planned Parenthood

Contraception Dec 20, 2017

Kohn JE, et al. - Researchers here perform a comparison of one-year continuation of subcutaneous depot medroxyprogesterone acetate (DMPA-sc) between women randomized to self-administration vs clinic administration. Observations reveal that self-administration of subcutaneous DMPA improves contraceptive continuation and is a feasible and acceptable option for women and adolescents
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay